2Moore RA, Edwards JE, Hopwood J, et al.Imiquimod for the treatment of genital warts:a quantitative systematic review. BMC Infect Dis, 2001, 1: 3.?A?A 被引量:1
3Tyring SK, Arany I, Stanley MA, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis,1998, 178: 551-555. 被引量:1
4Syed TA, Ahmadpour OA, Ahmad SA, et al. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study. J Dermatol, 1998, 25: 429-433. 被引量:1
3Syed TA, Ahmadpour OA, Ahmad SA, et al. Management of toenail onychomycosis with 2% butenafine and 20% urea cretan: a placebo-controlled, double-blind study. J Dermatol, 1998 , 25: 648-652. 被引量:1
4Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs, 1999 , 58: 375-390. 被引量:1
5Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol, 1998, 134: 25-30. 被引量:1
6Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol, 1998, 38(2 Pt 1 ): 230-239. 被引量:1
9Beutner KR,Spruance SL,Hougham A J,et al.Treatment of genital warts with an immune-response modifier (imiquimod).J Am Acad Dermatol,1998,38:230-239. 被引量:1
10Moore RA,Edwards JE,Hopwood J,et al.Imiquimod for the treatment of genital warts:a quantitative systematic review.BMC Infect Dis,2001,1:3. 被引量:1